Restimulating interest in cytomegalovirus as a cofactor for HIV infection

Journal of Infectious Diseases

Volumn 211, Issue 2, 2015, Pages 169-171

  Emery, Vincent C ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

cell entry; cofactors; herpesvirus; molecular mechanism; retrovirus

Indexed keywords

ACICLOVIR; CHEMOKINE RECEPTOR CCR5; IMMUNOGLOBULIN G; PLACEBO; CCR5 PROTEIN, HUMAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; CONTROLLED CLINICAL TRIAL (TOPIC); CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG MEGADOSE; HEMOPHILIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MACROPHAGE; MIXED INFECTION; MONONUCLEAR CELL; NONHUMAN; NOTE; SEROCONVERSION; SEROPREVALENCE; SURVIVAL; VIRAL TROPISM; VIRUS ENTRY; VIRUS REPLICATION; VIRUS TRANSMISSION; AIDS RELATED COMPLEX; CARDIOVASCULAR DISEASES; CD4+ T LYMPHOCYTE; CEREBROVASCULAR DISORDERS; COMPLICATION; CYTOMEGALOVIRUS; FEMALE; FETUS BLOOD; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MALE; PHYSIOLOGY; PREGNANCY; TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CARDIOVASCULAR DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CEREBROVASCULAR DISORDERS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL BLOOD; HIV INFECTIONS; HIV-1; HUMANS; MALE; PREGNANCY; RECEPTORS, CCR5;

EID: 84922565308     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu419     Document Type: Note

References (17)

1. Fishman JA, Rubin RH. Infection in organtransplant recipients. N Engl J Med 1998; 338:1741-51.
2. Fishman JA, Emery V, Freeman R, et al. Cytomegalovirus in transplantation-challenging the status quo. Clin Transplant 2007; 21:149-58.
3. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26:86-102.
4. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group. J Infect Dis 1997; 176:50-8.
5. Bowen EF, Emery VC, Wilson P, et al. Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis. AIDS 1998; 12:605-11.
6. Jeffery HC, Söderberg-Naucler C, Butler LM. Human cytomegalovirus induces a biphasic inflammatory response in primary endothelial cells. J Virol 2013; 87:6530-5.
7. Lachmann R, Bajwa M, Vita S, et al. Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses. J Virol 2012; 86:1001-9.
8. Webster A, Lee CA, Cook DG, et al. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 1989; 2:63-6.
9. Sabin CA, Phillips AN, Lee CA, Janossy G, Emery V, Griffiths PD. The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion. Epidemiol Infect 1995; 114: 361-72.
10. Youle MS, Gazzard BG, Johnson MA, et al. Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group [published correction appears in AIDS 1994; 8:859]. AIDS 1994; 8:641-9.
11. Ioannidis JP, Collier AC, Cooper DA, et al. Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-Analysis of randomized individual patient data. J Infect Dis 1998; 178:349-59.
12. Slyker JA, Lohman-Payne BL, Rowland-Jones SL, et al. The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS 2009; 23:117-24.
13. Potena L, Holweg CT, Chin C, et al. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation 2006; 82:398-405.
14. Terrazzini N, Bajwa M, Vita S, et al. A novel cytomegalovirus-induced regulatory-Type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology. J Infect Dis 2014; 209:1382-92.
15. Marashi SM, Raeiszadeh M, Workman S, et al. Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus. J Allergy Clin Immunol 2011; 127:1385-93.e4.
16. Griffiths PD. CMV as a cofactor enhancing progression of AIDS. J Clin Virol 2006; 35:489-92.
17. Chemaly RF, Ullmann AJ, Stoelben S, et al.; AIC246 Study Team. Letermovir for cytomegalovirus prophylaxis in hematopoieticcell transplantation. N Engl J Med 2014; 370:1781-9.